NewMarket
- Market cap
- 8.33B
- P/E (TTM)i
- 19.49
- P/Bi
- 4.53
- EPSi
- 44.44
- Div yieldi
- 1.30%
- 52W posi
- 82%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Fair Value how this is computed
- Implied fair-value range of 548.21-751.04, from this stock's own trailing 5-year average P/E applied to trailing EPS.
- Current price is +39.4% above the average-multiple fair value of 649.62.
Valuation each multiple against its own 5-year range
Vs. peers Specialty Chemicals
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| NewMarket (NEU) | 8.33B | 19.49 | 4.53 | 1.30% |
| Linde (LIN) | 223.11B | 31.22 | 5.71 | 1.28% |
| Ecolab (ECL) | 77.96B | 37.33 | 7.75 | 1.02% |
| Sherwin-Williams (SHW) | 76.47B | 29.06 | 19.84 | 1.01% |
| Air Products & Chemicals (APD) | 61.93B | -1,324.38 | 4.46 | 2.59% |
| PPG Industries (PPG) | 23.36B | 15.03 | 2.77 | 2.70% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 2.0% below Morningstar's fair value estimate.
Fair value
NewMarket Corp earns a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a price consistent with our quantitative fair value estimate, which has a high uncertainty rating.
The company's valuation metrics undermine our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's book value yield of 21.6% lies in the bottom 20% compared with peers globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which contributes to our balanced fair value estimate.
The company's balance sheet is an additional cause for concern. Low leverage can limit a company's ability to invest in growth, potentially reducing shareholder value compared with a balanced use of debt and equity financing. The firm's EBITDA/interest coverage ratio of 20.5, for example, lies in the top 45% compared with peers globally. The company may have too conservative of a balance sheet based on its high EBITDA/interest coverage ratio, potentially underinvesting in growth opportunities and undermining the long-term trajectory of cash flows. This characteristic further promotes our neutral price/fair value ratio.
Economic moat
The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.
By Quantitative Equity Report
Quote time 2026-10-08 05:23:50 · For reference only, not investment advice and not tailored to your situation.